Hoth Therapeutics Inc.

NASDAQ: HOTH · Real-Time Price · USD
1.28
-0.01 (-0.78%)
At close: Aug 15, 2025, 3:59 PM
1.32
3.12%
After-hours: Aug 15, 2025, 07:39 PM EDT

Hoth Therapeutics Balance Sheet Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Cash & Equivalents
9.01M 11.32M 7.04M 8.02M 9.65M 7.56M 9.29M 11.83M 11.54M 13.04M 6.43M 8.94M 11.32M 6.38M 8.54M 12.45M 15.85M 19.3M
Short-Term Investments
n/a n/a n/a n/a n/a n/a n/a 24.57K 24.57K 190.52K 209.32K 330.9K 304.33K 1.91M 1.89M 2.03M 1.58M 1.05M
Long-Term Investments
n/a 36.82K 36.82K 36.82K 36.82K 36.82K 37.4K 33K 33K 33K 33K 387.4K 387.4K 410K 410K 410K 410K 410K
Other Long-Term Assets
36.82K n/a n/a n/a n/a 550.5K n/a n/a n/a -0.00 n/a 0.00 n/a n/a n/a n/a 50K 50K
Receivables
n/a 46.77K 46.77K n/a n/a n/a 46.77K n/a n/a n/a n/a 50K 50K 50K 50K 50K n/a n/a
Inventory
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a -50K n/a n/a n/a n/a n/a
Other Current Assets
1.04M n/a n/a n/a n/a 550.5K -46.77K n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Total Current Assets
10.05M 12.29M 7.64M 8.24M 9.95M 8.41M 9.43M 12.05M 11.88M 13.43M 6.73M 9.51M 11.86M 8.54M 10.58M 14.78M 17.57M 20.53M
Property-Plant & Equipment
18.08K 24.51K 31.07K 33.81K 41.1K 48.22K 55.16K n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Goodwill & Intangibles
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Total Long-Term Assets
54.9K 61.33K 67.89K 70.63K 77.92K 635.54K 92.56K 33K 33K 33K 33K 387.4K 387.4K 410K 410K 410K 460K 460K
Total Assets
10.11M 12.36M 7.71M 8.31M 10.03M 8.49M 9.52M 12.09M 11.92M 13.46M 6.76M 9.89M 12.25M 8.95M 10.99M 15.19M 18.03M 20.99M
Account Payables
75.51K 469.4K 412.07K 504.81K 333.35K 360.9K 35.59K 707.18K 520.66K 782.83K 694.99K 930.92K 679.41K 699.81K 360.96K 1.3M 804.88K 581.22K
Deferred Revenue
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Short-Term Debt
21.33K n/a n/a n/a 30.06K 29.32K 28.84K n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Current Liabilities
343.3K n/a n/a n/a -30.06K -29.32K -28.84K n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Total Current Liabilities
364.63K 815.3K 831.2K 810.32K 680.82K 639.83K 678.66K 1.58M 1.72M 1.35M 1.39M 1.01M 753.67K 825.76K 867.79K 1.61M 1.22M 759.08K
Long-Term Debt
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Long-Term Liabilities
n/a n/a n/a n/a n/a n/a n/a n/a 250K 250K 250K 275K 275K 235K 235K 235K 235K 285K
Total Long-Term Liabilities
n/a n/a 2.71K 2.71K 11.04K 18.9K 26.33K n/a 250K 250K 250K 275K 275K 235K 235K 235K 235K 285K
Total Liabilities
364.63K 815.3K 833.91K 813.03K 691.86K 658.74K 704.98K 1.58M 1.97M 1.6M 1.64M 1.28M 1.03M 1.06M 1.1M 1.84M 1.45M 1.04M
Total Debt
21.33K 28.86K 31.07K 33.81K 41.1K 48.22K 55.16K n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Common Stock
1.32K 1.32K 804.00 690.00 536.00 440.00 435.00 435.00 330.00 330.00 130.00 129.00 3.22K 2.4K 2.4K 2.4K 2.39K 2.31K
Retained Earnings
-66.09M -63.89M -60.41M -58.75M -56.62M -54.99M -52.94M -51.24M -49.16M -47.28M -45.1M -41.62M -38.98M -36.3M -33.73M -30.25M -26.95M -23.68M
Comprehensive Income
12.04K 8.57K 9.06K 25.62K 23.13K 21.49K 27.26K 22.75K -23.71K 27.38K 22.01K 49.57K 28.09K 13.86K 17.59K 19.79K 186.00 -8.88K
Shareholders Equity
9.74M 11.54M 6.88M 7.49M 9.34M 7.83M 8.82M 10.51M 9.95M 11.87M 5.12M 8.61M 11.22M 7.88M 9.88M 13.35M 16.57M 19.95M
Total Investments
n/a 36.82K 36.82K 36.82K 36.82K 36.82K 37.4K 57.57K 24.57K 190.52K 242.32K 718.3K 691.73K 2.32M 2.3M 2.44M 1.99M 1.46M